Rhenium and Technetium Chemistry for Nuclear Medicine and Waste Management
This community develops chemical methods to synthesize, separate, and apply rhenium and technetium compounds, primarily for producing medical imaging agents and managing radioactive waste.
The research focuses on the synthesis of rhenium tricarbonyl complexes and their biological evaluation for tumor imaging and renal scintigraphy. A parallel strand addresses the separation of rhenium and technetium from aqueous solutions, waste acids, and spent nuclear fuel using anion exchange, adsorption, and metal-organic frameworks. Key recurring themes include the production of Technetium-99m generators, the recovery of rhenium from industrial byproducts, and the design of highly selective ligands for perrhenate and pertechnetate ions.
The largest share of the community's output is found in Technetium research, accounting for 23.5% of all Technetium research, and Rhenium research, accounting for 19.4% of all Rhenium research. Technetium also contributes the highest number of papers within this group, with 3,687 entries, while Rhenium follows with 4,168 papers.
The community comprises 13,087 papers, publishing most frequently in Inorganic Chemistry, Inorganica Chimica Acta, and the Journal of Radioanalytical and Nuclear Chemistry.
Recent work continues to focus on the separation of rhenium from waste acids and the development of adsorbents for Technetium-99m generators, alongside the optimization of radiolabeled compounds for tumor detection and inflammation imaging.